# Peg-interferon for Inactive Chronic Hepatitis B Carriers

> **NCT02992704** · PHASE2,PHASE3 · COMPLETED · sponsor: **Seng Gee Lim** · enrollment: 90 (actual)

## Conditions studied

- Chronic Hepatitis, B Virus
- Carrier of Viral Hepatitis Type B

## Interventions

- **DRUG:** Peginterferon Alfa-2A

## Key facts

- **NCT ID:** NCT02992704
- **Lead sponsor:** Seng Gee Lim
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992704, "Peg-interferon for Inactive Chronic Hepatitis B Carriers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02992704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*